Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2.
Trinitrobenzenes
Refinements to the Diagnostic Cost Group (DCG) model.
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP.
HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.
See All 18 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.
Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005 Jun; 36(6):1298-300.
View in:
PubMed
subject areas
Aged
Brain Ischemia
Cerebral Hemorrhage
Cerebrovascular Disorders
Female
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Recurrence
Regression Analysis
Risk
Severity of Illness Index
Stroke
Treatment Outcome
authors with profiles
Marc Fisher MD
Majaz Moonis MD